Tinkerbell
Researcher
Watcher of the Skies
Posts: 143
|
Post by Tinkerbell on Jul 27, 2017 22:33:47 GMT -5
I'm in Norwalk CT - we have one prescribing. In fact the MD is my endo (unrelated to diabetes) - she makes me proud!
|
|
Tinkerbell
Researcher
Watcher of the Skies
Posts: 143
|
Post by Tinkerbell on Jul 27, 2017 22:51:37 GMT -5
I live in White Plains, NY within a 10 mile circle is Stamford, Greenwich, Rye, Scarsdale, New Rochelle, and all I could find were 2 in Yonkers. Something is wrong with a sales force that can't find or motivate Docs in the most affluent area of the country. Actually, I put in a 50 mile radius from my location in CT 06851 and 155 prescribing MDs came up - Bridgeport, New Haven, Bronx, NYC, Plainville - too many to mention. Try again and put in a 50 miles radius. Maybe there's only a few endos in your area who are even willing to prescribe. I'm sure they've been called on by the area sales reps otherwise how could there be so few prescribers? But hey, if someone needs Afrezza in one of those affluent towns, tell 'em they can come to my 'hood.' Looks like we may have a whole lot of snappier docs in our not so affluent towns and to be sure, rich doesn't necessarily equate to being the sharpest tool in the shed. |
|
|
|
Post by prosper on Jul 28, 2017 8:14:07 GMT -5
Yes, but that includes all of New York City and northern NJ and CT out to almost Bridgeport. That's a population of almost 25 million and only 100 Docs?
|
|
Tinkerbell
Researcher
Watcher of the Skies
Posts: 143
|
Post by Tinkerbell on Jul 28, 2017 8:41:28 GMT -5
Yes, but that includes all of New York City and northern NJ and CT out to almost Bridgeport. That's a population of almost 25 million and only 100 Docs? Yes. Medical students don't normally go "wow, I want to be an endocrinologist." Not when they can choose to be a surgeon, peadiatrician, oncologist, and or other subspecialty. Nonetheless, as Afrezza starts to gain traction, diabetics may not want to wait weeks/months to see their endo so they'll start going to their primary care physicians and asking for Afrezza. This paradigm shift is going to take time because to endos, results matter. As they start coming in and they see what Afrezza is doing, they may be more inclined to tell their PCP colleagues that so long as they follow guidelines from the company, use the educational materials available to them and contact MannKind Cares if they need some support, prescribing Afrezza should be fine. You will note that not every physician listed in the extensive list you were able to pull up is an endocrinologist. And there's the point really. But, there must be a modicum of desire on the part of any physician to learn about Afrezza which truthfully, no company or sales rep can instill. |
|
|
|
Post by centralcoastinvestor on Jul 28, 2017 9:01:10 GMT -5
Yes, but that includes all of New York City and northern NJ and CT out to almost Bridgeport. That's a population of almost 25 million and only 100 Docs? Yes. Medical students don't normally go "wow, I want to be an endocrinologist." Not when they can choose to be a surgeon, peadiatrician, oncologist, and or other subspecialty. Nonetheless, as Afrezza starts to gain traction, diabetics may not want to wait weeks/months to see their endo so they'll start going to their primary care physicians and asking for Afrezza. This paradigm shift is going to take time because to endos, results matter. As they start coming in and they see what Afrezza is doing, they may be more inclined to tell their PCP colleagues that so long as they follow guidelines from the company, use the educational materials available to them and contact MannKind Cares if they need some support, prescribing Afrezza should be fine. You will note that not every physician listed in the extensive list you were able to pull up is an endocrinologist. And there's the point really. But, there must be a modicum of desire on the part of any physician to learn about Afrezza which truthfully, no company or sales rep can instill. In CA, my primary care doctor is now prescribing Afrezza and says it's working well for his patients. He is using his diabetic educator to train his patients on the starting titration process. I was able to share Afrezza info with him over the last year and a half thanks to helpful info provided by this board. |
|
|
|
Post by mnholdem on Jul 28, 2017 9:09:47 GMT -5
It's not so difficult to imagine how data transmitted from smart devices connected to CGMs will soon provide information that a family practitioner can easily interpret. It will likely change the entire diabetes treatment industry by reducing the reliance on endocrinologists to make treatment decisions.
Afrezza would, of course, benefit tremendously by this technology. |
|
Tinkerbell
Researcher
Watcher of the Skies
Posts: 143
|
Post by Tinkerbell on Jul 28, 2017 9:37:41 GMT -5
It's not so difficult to imagine how data transmitted from smart devices connected to CGMs will soon provide information that a family practitioner can easily interpret. It will likely change the entire diabetes treatment industry by reducing the reliance on endocrinologists to make treatment decisions.
Afrezza would, of course, benefit tremendously by this technology. Well said and in truth, aren't we as individuals ultimately responsible to make the best decisions to preserve our own health? That goes for dealing with any illness that may affect us. We have to be, within reason, our own MDs. Mr. Sparks said so in the Senate hearing yesterday. He said not only was he the patient but he was also his own caregiver. And that is why putting the brakes on medical research in this technological era is very short sighted. The more we understand about our own health with the use of technologies, the better equipped we will be to manage it ourselves real time. Diabetes is only one of the many illnesses that can be managed by using technology and it won't be the last. |
|
|
|
Post by peppy on Jul 28, 2017 9:52:41 GMT -5
It's not so difficult to imagine how data transmitted from smart devices connected to CGMs will soon provide information that a family practitioner can easily interpret. It will likely change the entire diabetes treatment industry by reducing the reliance on endocrinologists to make treatment decisions.
Afrezza would, of course, benefit tremendously by this technology. Well said and in truth, aren't we as individuals ultimately responsible to make the best decisions to preserve our own health? That goes for dealing with any illness that may affect us. We have to be, within reason, our own MDs. Mr. Sparks said so in the Senate hearing yesterday. He said not only was he the patient but he was also his own caregiver. And that is why putting the brakes on medical research in this technological era is very short sighted. The more we understand about our own health with the use of technologies, the better equipped we will be to manage it ourselves real time. Diabetes is only one of the many illnesses that can be managed by using technology and it won't be the last. quote: He said not only was he the patient but he was also his own caregiver. reply: we know this is true. The physician orders blood tests, HgA1c and K+ etc, and provides prescription availability. The patient manages the dis ease. Regarding: He said not only was he the patient but he was also his own caregiver. Physicians do not want to lose control? Continuous Glucose Monitors and Afrezza give the patient more control? Reminds me of Mitch McConnel, the Neanderthal's do not want to lose control.
|
|
|
|
Post by sportsrancho on Jul 28, 2017 10:28:57 GMT -5
Central,
In CA, my primary care doctor is now prescribing Afrezza and says it's working well for his patients. He is using his diabetic educator to train his patients on the starting titration process. I was able to share Afrezza info with him over the last year and a half thanks to helpful info provided by this board.
----------
This is so awesome! Think of the shareholders who have spent their time whining, instead of going out and telling doctors and people about Afrezza. Time well spent! Thank you:-)
|
|
|
|
Post by tchalaa on Jul 28, 2017 10:54:44 GMT -5
Central, In CA, my primary care doctor is now prescribing Afrezza and says it's working well for his patients. He is using his diabetic educator to train his patients on the starting titration process. I was able to share Afrezza info with him over the last year and a half thanks to helpful info provided by this board. ---------- This is so awesome! Think of the shareholders who have spent their time whining, instead of going out and telling doctors and people about Afrezza. Time well spent! Thank you:-) I have never invested myself with this level of engagment in an investment principally on the non financial aspect in a company where I am just a little shareholders. Due diligence has helped with argument to discuss diabetes Ha1c, time-in-range, BG and new OUTSULIN Warren Buffet said: make sure you understand the product and process of the company you invested in. |
|
|
|
Post by rockstarrick on Jul 28, 2017 11:06:33 GMT -5
Well said and in truth, aren't we as individuals ultimately responsible to make the best decisions to preserve our own health? That goes for dealing with any illness that may affect us. We have to be, within reason, our own MDs. Mr. Sparks said so in the Senate hearing yesterday. He said not only was he the patient but he was also his own caregiver. And that is why putting the brakes on medical research in this technological era is very short sighted. The more we understand about our own health with the use of technologies, the better equipped we will be to manage it ourselves real time. Diabetes is only one of the many illnesses that can be managed by using technology and it won't be the last. quote: He said not only was he the patient but he was also his own caregiver. reply: we know this is true. The physician orders blood tests, HgA1c and K+ etc, and provides prescription availability. The patient manages the dis ease. Regarding: He said not only was he the patient but he was also his own caregiver. Physicians do not want to lose control? Continuous Glucose Monitors and Afrezza give the patient more control? Reminds me of Mitch McConnel, the Neanderthal's do not want to lose control.
Yes, the continuous glucose monitors allow the PWD to see in nearly realtime, how effectively they are managing their disease. This allows PWD to react when they see a problem, rather than waiting for the 3 or 6 month appointment to find out how good or bad their A1c is. These CGM's not only track the performance of the PWD, it also tracks the performance of the Insulin product they are using !! Time in Range/Zone !! What a concept, kind of like spontaneous meals for people with Type1 and Type 2 Diabetes. This change in the way people treat Diabetes is going to happen, and like Seyhey said, Afrezza is as fast as Insulin is going to get, until a cure, it's as good as it gets. Good Luck Everybody Go Mannkind !! 🇺🇸 |
|
